PDS Biotechnology Corp — Director's Dealing 2022

Jun 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2022-06-02

Reporting Person: Brown Spencer D. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-02	Employee Stock Option (Right to Buy)	$4.22	A	150000	Acquired	2032-06-02	Common Stock (150000)	Direct

Footnotes

F1: This option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. This option, representing a right to purchase a total of 150,000 shares of Common Stock, will become exercisable on June 2, 2023, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.